These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23373454)

  • 1. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.
    Jones PS; Dunn GP; Barker FG; Curry WT; Hochberg FH; Cahill DP
    Neurosurg Focus; 2013 Feb; 34(2):E9. PubMed ID: 23373454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    Sturm D; Pfister SM; Jones DTW
    J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of gliomas.
    Appin CL; Brat DJ
    Cancer J; 2014; 20(1):66-72. PubMed ID: 24445767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma-derived mutations in IDH: from mechanism to potential therapy.
    Fu Y; Huang R; Du J; Yang R; An N; Liang A
    Biochem Biophys Res Commun; 2010 Jun; 397(2):127-30. PubMed ID: 20510884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma biology and molecular markers.
    Cohen AL; Colman H
    Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
    Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade glioma.
    Kumthekar P; Raizer J; Singh S
    Cancer Treat Res; 2015; 163():75-87. PubMed ID: 25468226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
    Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular biology of WHO grade II gliomas.
    Marko NF; Weil RJ
    Neurosurg Focus; 2013 Feb; 34(2):E1. PubMed ID: 23373446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
    Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
    Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
    Taylor JW; Chi AS; Cahill DP
    Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in circular RNAs and their role in glioma (Review).
    Zhang Y; Lin X; Geng X; Shi L; Li Q; Liu F; Fang C; Wang H
    Int J Oncol; 2020 Jul; 57(1):67-79. PubMed ID: 32319596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.